Eighteen‐month lamivudine prophylaxis on preventing occult hepatitis B virus infection reactivation in patients with haematological malignancies receiving immunosuppression therapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|25|2|198-204

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.25, Iss.2, 2018-02, pp. : 198-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy of Occult Hepatitis B Virus Infection and Prevention of Reactivation

By  

Intervirology, Vol. 57, Iss. 3-4, 2014-07 ,pp. : 189-195

Karger

Access to resources Recommend Favorite

Fatal Reactivation of Occult Hepatitis B Virus Infection after Rituximab and Chemotherapy in Lymphoma: Necessity of Antiviral Prophylaxis

By  

Oncology Research and Treatment, Vol. 33, Iss. 10, 2010-09 ,pp. : 537-539

Karger

Access to resources Recommend Favorite

Lamivudine Therapy for Decompensated Liver Cirrhosis Related to Hepatitis B Virus Infection

By  

Intervirology, Vol. 46, Iss. 6, 2003-12 ,pp. : 388-393

Karger

Access to resources Recommend Favorite

Postoperative hepatitis B virus reactivation and surgery‐induced immunosuppression in patients with hepatitis B‐related hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 6, 2015-11 ,pp. : 634-642

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Lamivudine in Patients with Hematologic Malignancies Receiving Chemotherapy and Precore Mutant Chronic Active Hepatitis B

By  

Acta Haematologica, Vol. 107, Iss. 1, 2002-01 ,pp. : 49-51

Karger

Access to resources Recommend Favorite